Partnership Limited GP Biofund Israel Orbimed Novus Therapeutics, Inc

As of December 4, 2020


Partnership Limited GP Biofund Israel Orbimed Net Worth

  • Net worth is estimated to be at least $60.53M
  • Owns at least 73,650 units of Novus Therapeutics, Inc stock
  • Sold an estimated value of $2.23M in the last 3 years at Novus Therapeutics, Inc

Partnership Limited GP Biofund Israel Orbimed Trading

  • Largest purchase of shares was 646,204 units , worth over $2M on May 6, 2019
  • Largest sale of shares was 103,200 units , worth over $2.23M on December 4, 2020
  • In total has made about 4 transactions over 3 years
  • Usually trades in May, with the busiest year in 2020

OrbiMed Israel GP Ltd, Partnership Limited GP BioFund Israel OrbiMed

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Partnership Limited GP Biofund Israel Orbimed Mailing Address

  • Mailing address is 601 Lexington Avenue, 54th Floor New York NY 1022-4629 NY

Novus Therapeutics, Inc Insider Trading

  • The most recent transaction was 103,200 units sold on December 4, 2020 by Orbimed Israel GP Ltd and Partnership Limited GP Biofund Israel Orbimed worth over $2.23M
  • In the last 3 years, insiders at Novus Therapeutics, Inc sold an estimated value of $2.63M and bought an estimated value of $7.31M
  • The most active traders are Catherine C Turkel, President,  Gregory J Flesher, Chief Executive Officer,  and Jon Kuwahara, See Remarks
  • Insider trading is most common in May, with the busiest year in 2019

Eledon Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1